OBJECTIVE: The aim of this study was to get a general idea of the antibody prevalence of toxoplasmosis within the different agegroups of the population of Mecklenburg-Western Pomerania. 4854 serums (collected between 1994 and 1996) from different institutions of the federal state were investigated with the "Toxo-Competitions Test LTXC)" at the Mini-Vidas divice (bio Merieux). MATERIAL AND METHODS: An antibody prevalence rate of 59% was found. As expected, with rising age a continuing increase was recognisable. The antibody prevalence rate with the male test persons amounted to 58.5%, with the female test persons to 59.3%, and within the pregnant women 63.2%. RESULTS: Therefore 36.8% of pregnant women have got no toxoplasmosis antibodies, i.e. they are exposed to the danger of a primary infection. Within pregnant women aged between 20 and 40 an increase of antibody prevalence of 1% per year of age was recognisable. There was only a small share of pregnant women (10.5%), but they confirm the facts known from literature. CONCLUSIONS: More than 1/3 of our test persons hadn't had toxoplasmosis antibodies. Therefore in order to reduce the danger of a primary infection in pregnant women a screening before pregnancy in recommendable.
OBJECTIVE: The aim of this study was to get a general idea of the antibody prevalence of toxoplasmosis within the different agegroups of the population of Mecklenburg-Western Pomerania. 4854 serums (collected between 1994 and 1996) from different institutions of the federal state were investigated with the "Toxo-Competitions Test LTXC)" at the Mini-Vidas divice (bio Merieux). MATERIAL AND METHODS: An antibody prevalence rate of 59% was found. As expected, with rising age a continuing increase was recognisable. The antibody prevalence rate with the male test persons amounted to 58.5%, with the female test persons to 59.3%, and within the pregnant women 63.2%. RESULTS: Therefore 36.8% of pregnant women have got no toxoplasmosis antibodies, i.e. they are exposed to the danger of a primary infection. Within pregnant women aged between 20 and 40 an increase of antibody prevalence of 1% per year of age was recognisable. There was only a small share of pregnant women (10.5%), but they confirm the facts known from literature. CONCLUSIONS: More than 1/3 of our test persons hadn't had toxoplasmosis antibodies. Therefore in order to reduce the danger of a primary infection in pregnant women a screening before pregnancy in recommendable.
Authors: Hussein Aqeely; Eman K El-Gayar; Darakhshan Perveen Khan; Abdullah Najmi; Ayesha Alvi; Ibrahim Bani; Mohamed Salih Mahfouz; Saif Elden Abdalla; Ibrahim M Elhassan Journal: J Trop Med Date: 2014-11-13
Authors: Alison Burrells; Marieke Opsteegh; Kevin G Pollock; Claire L Alexander; Jean Chatterton; Roger Evans; Robert Walker; Chris-Anne McKenzie; Dolores Hill; Elisabeth A Innes; Frank Katzer Journal: Parasit Vectors Date: 2016-06-07 Impact factor: 3.876